{"id":76988,"date":"2026-11-11T04:09:44","date_gmt":"2026-11-11T04:09:44","guid":{"rendered":"https:\/\/www.stocktargetadvisor.com\/blog\/?p=76988"},"modified":"2026-11-11T04:10:51","modified_gmt":"2026-11-11T04:10:51","slug":"american-analyst-updated-nov-10th-2026","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updated-nov-10th-2026\/","title":{"rendered":"American Analyst Updates: Nov 10th, 2026"},"content":{"rendered":"

Analyst Ratings (USA)<\/strong><\/a><\/h2>\n

American analyst sentiment on November 10th is mixed but cautiously optimistic, with positive recommendations concentrated in technology, artificial intelligence infrastructure, biotechnology, industrials, and select financial companies. New coverage and upgrades reflect confidence in long-term earnings growth and structural investment opportunities, particularly in cloud computing, critical minerals, and infrastructure. However, widespread price-target reductions and downgrades across software, consumer discretionary, gaming, and emerging technology companies highlight increasing concerns about valuations, profitability, and slowing growth expectations.<\/p>\n

Updates (322)<\/strong><\/h3>\n

AAON Inc. (AAON)<\/strong> \u2014 Oppenheimer maintains its Outperform rating and lowers its price target to $105.00 from $115.00.<\/p>\n

AAON Inc. (AAON)<\/strong> \u2014 Robert W. Baird maintains its Outperform rating and lowers its price target to $104.00 from $110.00.<\/p>\n

AbCellera Biologics (ABCL)<\/strong> \u2014 Stifel Nicolaus maintains its Buy rating and raises its price target to $14.00 from $9.00.<\/p>\n

Abercrombie & Fitch (ANF)<\/strong> \u2014 The Goldman Sachs Group reiterates its Buy rating with a price target of $180.00.<\/p>\n

Academy Sports + Outdoors (ASO)<\/strong> \u2014 Cantor Fitzgerald initiates coverage with an Overweight rating with a price target of $89.00.<\/p>\n

Academy Sports + Outdoors (ASO)<\/strong> \u2014 Loop Capital downgrades the stock from Buy to Hold with a price target of $69.00.<\/p>\n

Adaptive Biotechnologies (ADPT)<\/strong> \u2014 Guggenheim maintains its Buy rating and raises its price target to $34.00 from $32.00.<\/p>\n

AerSale (ASLE)<\/strong> \u2014 Royal Bank Of Canada maintains its Sector Perform rating and lowers its price target to $6.00 from $7.00.<\/p>\n

Affiliated Managers Group (AMG)<\/strong> \u2014 TD Cowen maintains its Buy rating and raises its price target to $583.00 from $523.00.<\/p>\n

Allstate (ALL)<\/strong> \u2014 Keefe, Bruyette & Woods maintains its Underperform rating and raises its price target to $241.00 from $232.00.<\/p>\n

Allstate (ALL)<\/strong> \u2014 Morgan Stanley maintains its Equal Weight rating and raises its price target to $260.00 from $240.00.<\/p>\n

Allstate (ALL)<\/strong> \u2014 UBS Group maintains its Neutral rating and raises its price target to $283.00 from $275.00.<\/p>\n

Alvotech (ALVO)<\/strong> \u2014 Jefferies initiates coverage with a Buy rating with a price target of $9.00.<\/p>\n

Amcor (AMCR)<\/strong> \u2014 Citigroup maintains its Buy rating and lowers its price target to $50.00 from $52.00.<\/p>\n

Amer Sports (AS)<\/strong> \u2014 Cantor Fitzgerald initiates coverage with an Overweight rating with a price target of $46.00.<\/p>\n

American Axle & Manufacturing (DCH)<\/strong> \u2014 Stifel Nicolaus maintains its Hold rating and lowers its price target to $5.00 from $6.00.<\/p>\n

American Healthcare REIT (AHR)<\/strong> \u2014 Citigroup maintains its Buy rating and raises its price target to $67.00 from $65.00.<\/p>\n

American Healthcare REIT (AHR)<\/strong> \u2014 Raymond James Financial reiterates its Strong-Buy rating with a price target of $72.00.<\/p>\n

American Healthcare REIT (AHR)<\/strong> \u2014 Royal Bank Of Canada maintains its Outperform rating and raises its price target to $66.00 from $61.00.<\/p>\n

American International Group (AIG)<\/strong> \u2014 UBS Group maintains its Buy rating and raises its price target to $103.00 from $100.00.<\/p>\n

American Public Education (APEI)<\/strong> \u2014 B. Riley Financial maintains its Buy rating and raises its price target to $68.00 from $65.00.<\/p>\n

Amylyx Pharmaceuticals (AMLX)<\/strong> \u2014 Mizuho maintains its Outperform rating and raises its price target to $39.00 from $38.00.<\/p>\n

Angi (ANGI)<\/strong> \u2014 UBS Group maintains its Neutral rating and raises its price target to $9.00 from $5.00.<\/p>\n

Antero Midstream (AM)<\/strong> \u2014 Morgan Stanley maintains its Equal Weight rating and lowers its price target to $24.00 from $26.00.<\/p>\n

Apple Hospitality REIT (APLE)<\/strong> \u2014 Cantor Fitzgerald maintains its Overweight rating and raises its price target to $22.00 from $18.00.<\/p>\n

Archer Aviation (ACHR)<\/strong> \u2014 Cantor Fitzgerald maintains its Overweight rating and lowers its price target to $10.00 from $11.00.<\/p>\n

Archer Aviation (ACHR)<\/strong> \u2014 Needham & Company LLC maintains its Buy rating and lowers its price target to $7.00 from $9.00.<\/p>\n

Arcos Dorados (ARCO)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Overweight rating and lowers its price target to $10.00 from $10.50.<\/p>\n

Arhaus (ARHS)<\/strong> \u2014 Guggenheim maintains its Buy rating and raises its price target to $17.00 from $12.00.<\/p>\n

ArriVent BioPharma (AVBP)<\/strong> \u2014 Truist Financial maintains its Buy rating and raises its price target to $24.00 from $21.00.<\/p>\n

Assurant (AIZ)<\/strong> \u2014 UBS Group maintains its Buy rating and raises its price target to $377.00 from $331.00.<\/p>\n

AST SpaceMobile (ASTS)<\/strong> \u2014 B. Riley Financial maintains its Neutral rating and lowers its price target to $48.00 from $65.00.<\/p>\n

AST SpaceMobile (ASTS)<\/strong> \u2014 Bank of America reiterates its Neutral rating.<\/p>\n

AST SpaceMobile (ASTS)<\/strong> \u2014 Citigroup reiterates its Positive rating.<\/p>\n

AST SpaceMobile (ASTS)<\/strong> \u2014 UBS Group maintains its Neutral rating and lowers its price target to $43.00 from $78.00.<\/p>\n

Atlanticus (ATLC)<\/strong> \u2014 Citigroup reiterates its Market Outperform rating.<\/p>\n

Atlanticus (ATLC)<\/strong> \u2014 Citizens Jmp maintains its Market Outperform rating and raises its price target to $117.00 from $110.00.<\/p>\n

Aura Biosciences (AURA)<\/strong> \u2014 Citigroup reiterates its Market Outperform rating.<\/p>\n

AvePoint (AVPT)<\/strong> \u2014 Morgan Stanley downgrades the stock from Overweight to Equal Weight.<\/p>\n

Babcock (BW)<\/strong> \u2014 Needham & Company LLC maintains its Buy rating and lowers its price target to $15.00 from $20.00.<\/p>\n

Barrick Mining (B)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Overweight rating and lowers its price target to $53.00 from $55.00.<\/p>\n

Becton, Dickinson and Company (BDX)<\/strong> \u2014 Barclays maintains its Underweight rating and raises its price target to $195.00 from $165.00.<\/p>\n

Better Home & Finance (BETR)<\/strong> \u2014 B. Riley Financial maintains its Buy rating and lowers its price target to $23.00 from $26.00.<\/p>\n

Better Home & Finance (BETR)<\/strong> \u2014 Needham & Company LLC reiterates its Buy rating with a price target of $22.00.<\/p>\n

Bicara Therapeutics (BCAX)<\/strong> \u2014 BTIG Research maintains its Buy rating and lowers its price target to $37.00 from $39.00.<\/p>\n

Bicara Therapeutics (BCAX)<\/strong> \u2014 Citigroup reiterates its Market Outperform rating.<\/p>\n

Bicara Therapeutics (BCAX)<\/strong> \u2014 Morgan Stanley maintains its Overweight rating and lowers its price target to $30.00 from $41.00.<\/p>\n

Bicara Therapeutics (BCAX)<\/strong> \u2014 Stifel Nicolaus maintains its Buy rating and lowers its price target to $43.00 from $45.00.<\/p>\n

Billiontoone (BLLN)<\/strong> \u2014 Piper Sandler maintains its Overweight rating and lowers its price target to $130.00 from $140.00.<\/p>\n

Black Diamond Therapeutics (BDTX)<\/strong> \u2014 Raymond James Financial reiterates its Outperform rating.<\/p>\n

BlackSky Technology (BKSY)<\/strong> \u2014 Jefferies Financial Group reiterates its Hold rating with a price target of $27.00.<\/p>\n

Blackstone Secured Lending Fund (BXSL)<\/strong> \u2014 B. Riley Financial maintains its Neutral rating and lowers its price target to $22.50 from $23.50.<\/p>\n

Booz Allen Hamilton (BAH)<\/strong> \u2014 Citigroup maintains its Neutral rating and raises its price target to $94.00 from $88.00.<\/p>\n

British American Tobacco (BTI)<\/strong> \u2014 JP Morgan resumes coverage with an Overweight rating.<\/p>\n

British American Tobacco (BTI)<\/strong> \u2014 JPMorgan Chase & Co. initiates coverage with an Overweight rating.<\/p>\n

Brookdale Senior Living (BKD)<\/strong> \u2014 Barclays maintains its Overweight rating and lowers its price target to $14.00 from $17.00.<\/p>\n

Brookfield (BN)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Overweight rating and raises its price target to $65.00 from $56.00.<\/p>\n

BTGO (BTGO)<\/strong> \u2014 Canaccord Genuity Group maintains its Buy rating and lowers its price target to $12.00 from $15.00.<\/p>\n

BTGO (BTGO)<\/strong> \u2014 Mizuho maintains its Outperform rating and lowers its price target to $9.00 from $11.00.<\/p>\n

BTGO (BTGO)<\/strong> \u2014 Rosenblatt Securities maintains its Buy rating and lowers its price target to $9.00 from $10.00.<\/p>\n

BTGO (BTGO)<\/strong> \u2014 Wells Fargo & Company maintains its Overweight rating and lowers its price target to $9.00 from $11.00.<\/p>\n

Burlington Stores (BURL)<\/strong> \u2014 Cantor Fitzgerald initiates coverage with a Neutral rating with a price target of $270.00.<\/p>\n

Cabot (CBT)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Underweight rating and lowers its price target to $68.00 from $78.00.<\/p>\n

Camden Property Trust (CPT)<\/strong> \u2014 UBS Group maintains its Neutral rating and raises its price target to $107.00 from $101.00.<\/p>\n

Cardinal Health (CAH)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Neutral rating and raises its price target to $286.00 from $260.00.<\/p>\n

CareTrust REIT (CTRE)<\/strong> \u2014 Raymond James Financial reiterates its Outperform rating with a price target of $41.00.<\/p>\n

Caris Life Sciences (CAI)<\/strong> \u2014 Piper Sandler maintains its Neutral rating and raises its price target to $25.00 from $22.00.<\/p>\n

Carlyle Group (CG)<\/strong> \u2014 The Goldman Sachs Group maintains its Buy rating and lowers its price target to $58.00 from $66.00.<\/p>\n

Carlyle Group (CG)<\/strong> \u2014 UBS downgrades the stock from Buy to Neutral and lowers its price target to $47.00 from $60.00.<\/p>\n

Carvana (CVNA)<\/strong> \u2014 Argus sets a price target of $100.00.<\/p>\n

Celanese (CE)<\/strong> \u2014 UBS Group maintains its Neutral rating and raises its price target to $58.00 from $53.00.<\/p>\n

Cencora (COR)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Overweight rating and raises its price target to $413.00 from $390.00.<\/p>\n

Centerspace (CSR)<\/strong> \u2014 UBS Group maintains its Neutral rating and raises its price target to $68.00 from $65.00.<\/p>\n

Ceva (CEVA)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Neutral rating and lowers its price target to $35.00 from $45.00.<\/p>\n

Ceva (CEVA)<\/strong> \u2014 Oppenheimer maintains its Outperform rating and lowers its price target to $35.00 from $38.00.<\/p>\n

Ceva (CEVA)<\/strong> \u2014 Stifel Nicolaus maintains its Buy rating and lowers its price target to $40.00 from $50.00.<\/p>\n

Ceva (CEVA)<\/strong> \u2014 UBS Group maintains its Buy rating and lowers its price target to $35.00 from $40.00.<\/p>\n

Charter Communications (CHTR)<\/strong> \u2014 Citigroup maintains its Buy rating and raises its price target to $150.00 from $140.00.<\/p>\n

Chord Energy (CHRD)<\/strong> \u2014 UBS Group maintains its Buy rating and raises its price target to $198.00 from $197.00.<\/p>\n

Cipher Mining (CIFR)<\/strong> \u2014 Jefferies Financial Group maintains its Buy rating and lowers its price target to $10.00 from $12.00.<\/p>\n

City (CHCO)<\/strong> \u2014 Jefferies Financial Group initiates coverage with a Buy rating.<\/p>\n

City Therapeutics (CTY)<\/strong> \u2014 Jefferies initiates coverage with a Buy rating with a price target of $32.00.<\/p>\n

City Therapeutics (CTY)<\/strong> \u2014 Oppenheimer initiates coverage with an Outperform rating with a price target of $46.00.<\/p>\n

City Therapeutics (CTY)<\/strong> \u2014 Stifel initiates coverage with a Buy rating with a price target of $34.00.<\/p>\n

City Therapeutics (CTY)<\/strong> \u2014 The Goldman Sachs Group initiates coverage with an Early-Stage Biotech rating.<\/p>\n

Clarus (CLAR)<\/strong> \u2014 B. Riley Financial maintains its Buy rating and raises its price target to $6.00 from $4.50.<\/p>\n

Cloudflare (NET)<\/strong> \u2014 DZ Bank upgrades the stock from Sell to Buy with a price target of $300.00.<\/p>\n

CNH Industrial (CNH)<\/strong> \u2014 Barclays maintains its Overweight rating and raises its price target to $15.00 from $14.00.<\/p>\n

CNH Industrial (CNH)<\/strong> \u2014 Citigroup maintains its Buy rating and raises its price target to $15.00 from $13.00.<\/p>\n

CNH Industrial (CNH)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Underweight rating and raises its price target to $12.00 from $11.00.<\/p>\n

CNH Industrial (CNH)<\/strong> \u2014 Raymond James Financial reiterates its Outperform rating with a price target of $15.00.<\/p>\n

CNH Industrial (CNH)<\/strong> \u2014 Robert W. Baird maintains its Outperform rating and raises its price target to $16.00 from $15.00.<\/p>\n

CNH Industrial (CNH)<\/strong> \u2014 Sanford C. Bernstein reiterates its Market Perform rating with a price target of $12.00.<\/p>\n

CNH Industrial (CNH)<\/strong> \u2014 Truist Financial maintains its Buy rating and lowers its price target to $16.00 from $17.00.<\/p>\n

Comfort Systems (FIX)<\/strong> \u2014 JP Morgan initiates coverage with an Overweight rating with a price target of $1,700.00.<\/p>\n

Comfort Systems USA (FIX)<\/strong> \u2014 JPMorgan Chase & Co. initiates coverage with an Overweight rating with a price target of $1,700.00.<\/p>\n

Compass Therapeutics (CMPX)<\/strong> \u2014 Wedbush maintains its Neutral rating and lowers its price target to $0.90 from $1.00.<\/p>\n

Cooper-Standard (CPS)<\/strong> \u2014 Stifel Nicolaus maintains its Buy rating and lowers its price target to $29.00 from $32.00.<\/p>\n

Core Scientific (CORZ)<\/strong> \u2014 Citigroup reiterates its Market Outperform rating.<\/p>\n

CorMedix (CRMD)<\/strong> \u2014 Citigroup reiterates its Market Outperform rating.<\/p>\n

CorMedix (CRMD)<\/strong> \u2014 Needham & Company LLC maintains its Buy rating and raises its price target to $14.00 from $12.00.<\/p>\n

CorMedix (CRMD)<\/strong> \u2014 Royal Bank Of Canada maintains its Outperform rating and raises its price target to $15.00 from $14.00.<\/p>\n

CorMedix (CRMD)<\/strong> \u2014 UBS Group sets a price target of $19.00.<\/p>\n

Costco (COST)<\/strong> \u2014 Freedom Broker downgrades the stock from Buy to Hold and raises its price target to $1,050.00 from $1,010.00.<\/p>\n

CRISPR Therapeutics (CRSP)<\/strong> \u2014 Piper Sandler reiterates its Overweight rating with a price target of $110.00.<\/p>\n

Criteo (CRTO)<\/strong> \u2014 Morgan Stanley maintains its Equal Weight rating and lowers its price target to $20.00 from $25.00.<\/p>\n

Csquare (CSQR)<\/strong> \u2014 Bank of America reiterates its Buy rating.<\/p>\n

Csquare (CSQR)<\/strong> \u2014 Sanford C. Bernstein reiterates its Outperform rating with a price target of $28.00.<\/p>\n

Csquare (CSQR)<\/strong> \u2014 TD Cowen maintains its Buy rating and raises its price target to $30.00 from $28.00.<\/p>\n

Cummins (CMI)<\/strong> \u2014 UBS Group maintains its Buy rating and lowers its price target to $675.00 from $741.00.<\/p>\n

Curtiss-Wright (CW)<\/strong> \u2014 Citigroup maintains its Neutral rating and lowers its price target to $505.00 from $622.00.<\/p>\n

Cytek Biosciences (CTKB)<\/strong> \u2014 Stephens maintains its Overweight rating and raises its price target to $7.00 from $6.00.<\/p>\n

Deckers Outdoor (DECK)<\/strong> \u2014 Cantor Fitzgerald initiates coverage with a Neutral rating with a price target of $89.00.<\/p>\n

Definium Therapeutics (DFTX)<\/strong> \u2014 Royal Bank Of Canada maintains its Outperform rating and raises its price target to $70.00 from $66.00.<\/p>\n

Delcath Systems (DCTH)<\/strong> \u2014 HC Wainwright maintains its Buy rating and raises its price target to $36.00 from $32.00.<\/p>\n

Devon Energy (DVN)<\/strong> \u2014 UBS Group maintains its Buy rating and lowers its price target to $62.00 from $65.00.<\/p>\n

Dick’s Sporting Goods (DKS)<\/strong> \u2014 Cantor Fitzgerald initiates coverage with a Neutral rating with a price target of $146.00.<\/p>\n

Docebo (DCBO)<\/strong> \u2014 Scotiabank maintains its Sector Outperform rating and raises its price target to $35.00 from $25.00.<\/p>\n

DocGo (DCGO)<\/strong> \u2014 Needham & Company LLC maintains its Buy rating and lowers its price target to $1.00.<\/p>\n

DraftKings (DKNG)<\/strong> \u2014 Berenberg downgrades the stock from Buy to Hold with a price target of $20.00.<\/p>\n

DraftKings (DKNG)<\/strong> \u2014 Citigroup maintains its Buy rating and lowers its price target to $22.00 from $28.00.<\/p>\n

DraftKings (DKNG)<\/strong> \u2014 Wells Fargo downgrades the stock from Overweight to Equal Weight with a price target of $21.00.<\/p>\n

e.l.f. Beauty (ELF)<\/strong> \u2014 Morgan Stanley maintains its Equal Weight rating and raises its price target to $125.00 from $103.00.<\/p>\n

East West Banc (EWBC)<\/strong> \u2014 Hovde Group initiates coverage with an Outperform rating with a price target of $153.00.<\/p>\n

Edgewell Personal Care (EPC)<\/strong> \u2014 Royal Bank Of Canada reiterates its Outperform rating with a price target of $35.00.<\/p>\n

Electra Battery Materials (ELBM)<\/strong> \u2014 HC Wainwright reiterates its Buy rating with a price target of $2.00.<\/p>\n

EMCOR Group (EME)<\/strong> \u2014 JP Morgan initiates coverage with a Neutral rating with a price target of $700.00.<\/p>\n

EMCOR Group (EME)<\/strong> \u2014 JPMorgan Chase & Co. initiates coverage with a Neutral rating with a price target of $700.00.<\/p>\n

Endeavour Silver (EXK)<\/strong> \u2014 HC Wainwright maintains its Buy rating and lowers its price target to $16.75 from $17.00.<\/p>\n

EOG Resources (EOG)<\/strong> \u2014 Susquehanna maintains its Positive rating and raises its price target to $196.00 from $187.00.<\/p>\n

Essex Property Trust (ESS)<\/strong> \u2014 Truist Financial maintains its Hold rating and raises its price target to $288.00 from $286.00.<\/p>\n

Essex Property Trust (ESS)<\/strong> \u2014 UBS Group maintains its Neutral rating and raises its price target to $286.00 from $275.00.<\/p>\n

Estee Lauder Companies (EL)<\/strong> \u2014 Citigroup maintains its Buy rating and raises its price target to $132.00 from $121.00.<\/p>\n

Eton Pharmaceuticals (ETON)<\/strong> \u2014 B. Riley Financial maintains its Buy rating and raises its price target to $81.00 from $70.00.<\/p>\n

Everus Construction Group (ECG)<\/strong> \u2014 Cantor Fitzgerald maintains its Neutral rating and lowers its price target to $123.00 from $152.00.<\/p>\n

Everus Construction Group (ECG)<\/strong> \u2014 Stifel Nicolaus maintains its Buy rating and lowers its price target to $139.00 from $172.00.<\/p>\n

EVgo Inc. (EVGO)<\/strong> \u2014 RBC Capital Mkts downgrades the stock from Outperform to Sector Perform and raises its price target to $2.00 from $1.75.<\/p>\n

EVgo Inc. (EVGO)<\/strong> \u2014 Roth Capital downgrades the stock from Buy to Neutral with a price target of $2.00.<\/p>\n

Excelerate Energy (EE)<\/strong> \u2014 Wells Fargo & Company maintains its Equal Weight rating and raises its price target to $40.00 from $38.00.<\/p>\n

Ferguson (FERG)<\/strong> \u2014 Barclays maintains its Overweight rating and raises its price target to $314.00 from $313.00.<\/p>\n

Ferguson (FERG)<\/strong> \u2014 Oppenheimer maintains its Outperform rating and raises its price target to $296.00 from $288.00.<\/p>\n

Ferguson (FERG)<\/strong> \u2014 Robert W. Baird maintains its Outperform rating and raises its price target to $300.00 from $288.00.<\/p>\n

Ferguson (FERG)<\/strong> \u2014 Royal Bank Of Canada maintains its Outperform rating and raises its price target to $288.00 from $286.00.<\/p>\n

Ferguson (FERG)<\/strong> \u2014 Sanford C. Bernstein reiterates its Outperform rating.<\/p>\n

Ferguson (FERG)<\/strong> \u2014 UBS Group maintains its Neutral rating and raises its price target to $270.00 from $256.00.<\/p>\n

Fervo Energy (FRVO)<\/strong> \u2014 Robert W. Baird maintains its Outperform rating and lowers its price target to $20.00 from $26.00.<\/p>\n

Fidelity National Financial (FNF)<\/strong> \u2014 Keefe, Bruyette & Woods maintains its Outperform rating and raises its price target to $55.00 from $53.00.<\/p>\n

FIGS, Inc. (FIGS)<\/strong> \u2014 Cantor Fitzgerald initiates coverage with an Overweight rating with a price target of $25.00.<\/p>\n

First Advantage (FA)<\/strong> \u2014 Citigroup maintains its Neutral rating and raises its price target to $25.00 from $22.00.<\/p>\n

First Solar (FSLR)<\/strong> \u2014 UBS Group maintains its Buy rating and lowers its price target to $295.00 from $330.00.<\/p>\n

Fiserv (FISV)<\/strong> \u2014 Truist Financial maintains its Hold rating and raises its price target to $65.00 from $51.00.<\/p>\n

Flowco (FLOC)<\/strong> \u2014 Citigroup maintains its Neutral rating and lowers its price target to $25.00 from $27.00.<\/p>\n

Flutter Entertainment (FLUT)<\/strong> \u2014 Cfra downgrades the stock to Buy ? Hold with a price target of $94.00.<\/p>\n

Forward Air (FWRD)<\/strong> \u2014 Stifel Nicolaus maintains its Buy rating and raises its price target to $28.00 from $27.00.<\/p>\n

Fulgent Genetics (FLGT)<\/strong> \u2014 Piper Sandler maintains its Neutral rating and raises its price target to $25.00 from $19.00.<\/p>\n

GCM Grosvenor (GCMG)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Neutral rating and raises its price target to $14.50 from $13.00.<\/p>\n

GCM Grosvenor (GCMG)<\/strong> \u2014 Piper Sandler maintains its Overweight rating and raises its price target to $15.00 from $14.50.<\/p>\n

GE Vernova (GEV)<\/strong> \u2014 Glj Research reiterates its Sell rating with a price target of $540.00.<\/p>\n

GeneDx (WGS)<\/strong> \u2014 BTIG Research maintains its Buy rating and lowers its price target to $85.00 from $90.00.<\/p>\n

Gilat Satellite (GILT)<\/strong> \u2014 William Blair downgrades the stock from Outperform to Market Perform.<\/p>\n

Global Payments (GPN)<\/strong> \u2014 Mizuho maintains its Outperform rating and sets a price target of $115.00 from $110.00.<\/p>\n

Goldman Sachs BDC (GSBD)<\/strong> \u2014 Truist Financial maintains its Hold rating and lowers its price target to $9.00 from $10.00.<\/p>\n

Goosehead Insurance (GSHD)<\/strong> \u2014 Piper Sandler maintains its Neutral rating and raises its price target to $56.00 from $48.00.<\/p>\n

GRAIL (GRAL)<\/strong> \u2014 Piper Sandler maintains its Neutral rating and raises its price target to $130.00 from $74.00.<\/p>\n

Greystone Housing Impact Investors (GHI)<\/strong> \u2014 JonesTrading maintains its Buy rating and lowers its price target to $6.00 from $7.00.<\/p>\n

Guardant Health (GH)<\/strong> \u2014 Piper Sandler maintains its Overweight rating and lowers its price target to $190.00 from $193.00.<\/p>\n

Gulfport Energy (GPOR)<\/strong> \u2014 UBS Group maintains its Buy rating and lowers its price target to $217.00 from $218.00.<\/p>\n

H&R Block (HRB)<\/strong> \u2014 The Goldman Sachs Group maintains its Sell rating and raises its price target to $40.00 from $36.00.<\/p>\n

The Hain Celestial Group (HAIN)<\/strong> \u2014 Barclays maintains its Underweight rating and lowers its price target to $0.10 from $0.30.<\/p>\n

Harley-Davidson (HOG)<\/strong> \u2014 Argus sets a price target of $38.00.<\/p>\n

Hims & Hers Health (HIMS)<\/strong> \u2014 Jefferies Financial Group maintains its Hold rating and lowers its price target to $24.00 from $31.00.<\/p>\n

Hims & Hers Health (HIMS)<\/strong> \u2014 Morgan Stanley maintains its Equal Weight rating and lowers its price target to $25.00 from $28.00.<\/p>\n

Hims & Hers Health (HIMS)<\/strong> \u2014 Needham & Company LLC maintains its Buy rating and lowers its price target to $32.00 from $42.00.<\/p>\n

HIVE Digital Technologies (HIVE)<\/strong> \u2014 Chardan Capital maintains its Buy rating and lowers its price target to $7.00 from $7.50.<\/p>\n

Home Depot (HD)<\/strong> \u2014 Sanford C. Bernstein maintains its Market Perform rating and raises its price target to $357.00 from $344.00.<\/p>\n

Horizon Technology Finance (HRZN)<\/strong> \u2014 B. Riley Financial maintains its Neutral rating and lowers its price target to $4.50 from $5.00.<\/p>\n

Horizon Technology Finance (HRZN)<\/strong> \u2014 UBS Group maintains its Neutral rating and lowers its price target to $3.75 from $4.50.<\/p>\n

Host Hotels & Resorts (HST)<\/strong> \u2014 Cantor Fitzgerald maintains its Neutral rating and raises its price target to $27.00 from $24.00.<\/p>\n

Humacyte (HUMA)<\/strong> \u2014 BTIG Research reiterates its Buy rating with a price target of $2.00.<\/p>\n

Humana (HUM)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Neutral rating and raises its price target to $484.00 from $393.00.<\/p>\n

Huntington Ingalls Industries (HII)<\/strong> \u2014 Citigroup maintains its Buy rating and lowers its price target to $352.00 from $379.00.<\/p>\n

Hut 8 (HUT)<\/strong> \u2014 Jefferies Financial Group maintains its Buy rating and lowers its price target to $81.00 from $90.00.<\/p>\n

Iambic Therapeutics (IAM)<\/strong> \u2014 Jefferies initiates coverage with a Buy rating with a price target of $35.00.<\/p>\n

IBEX (IBEX)<\/strong> \u2014 Royal Bank Of Canada maintains its Sector Perform rating and raises its price target to $45.00 from $40.00.<\/p>\n

Immunocore (IMCR)<\/strong> \u2014 HC Wainwright maintains its Buy rating and lowers its price target to $80.00 from $100.00.<\/p>\n

Immunome (IMNM)<\/strong> \u2014 Piper Sandler maintains its Overweight rating and lowers its price target to $30.00 from $33.00.<\/p>\n

Immunome (IMNM)<\/strong> \u2014 Stifel Nicolaus maintains its Hold rating and lowers its price target to $23.00 from $24.00.<\/p>\n

Immunovant (IMVT)<\/strong> \u2014 Truist Financial maintains its Hold rating and raises its price target to $33.00 from $30.00.<\/p>\n

Immunovant (IMVT)<\/strong> \u2014 Wells Fargo & Company maintains its Overweight rating and raises its price target to $47.00 from $45.00.<\/p>\n

Independence Realty Trust (IRT)<\/strong> \u2014 UBS Group maintains its Buy rating and raises its price target to $18.00 from $17.00.<\/p>\n

Ionis Pharmaceuticals (IONS)<\/strong> \u2014 Bank of America reiterates its Buy rating.<\/p>\n

Ionis Pharmaceuticals (IONS)<\/strong> \u2014 HC Wainwright maintains its Buy rating and lowers its price target to $70.00 from $100.00.<\/p>\n

Ionis Pharmaceuticals (IONS)<\/strong> \u2014 Morgan Stanley maintains its Overweight rating and lowers its price target to $75.00 from $104.00.<\/p>\n

Ionis Pharmaceuticals (IONS)<\/strong> \u2014 Oppenheimer maintains its Outperform rating and lowers its price target to $70.00 from $85.00.<\/p>\n

Ionis Pharmaceuticals (IONS)<\/strong> \u2014 Royal Bank Of Canada maintains its Outperform rating and lowers its price target to $60.00 from $85.00.<\/p>\n

Ionis Pharmaceuticals (IONS)<\/strong> \u2014 TD Cowen maintains its Buy rating and lowers its price target to $53.00 from $84.00.<\/p>\n

Ionis Pharmaceuticals (IONS)<\/strong> \u2014 The Goldman Sachs Group maintains its Neutral rating and lowers its price target to $41.00 from $58.00.<\/p>\n

Ionis Pharmaceuticals (IONS)<\/strong> \u2014 Wells Fargo & Company maintains its Overweight rating and lowers its price target to $80.00 from $95.00.<\/p>\n

JetBlue Airways (JBLU)<\/strong> \u2014 UBS Group maintains its Neutral rating and raises its price target to $4.00 from $3.50.<\/p>\n

JinkoSolar (JKS)<\/strong> \u2014 Glj Research maintains its Sell rating and lowers its price target to $5.27 from $12.08.<\/p>\n

Kinetik (KNTK)<\/strong> \u2014 Morgan Stanley maintains its Overweight rating and lowers its price target to $64.00 from $67.00.<\/p>\n

KKR & Co. Inc. (KKR)<\/strong> \u2014 Morgan Stanley maintains its Overweight rating and raises its price target to $140.00 from $138.00.<\/p>\n

KKR & Co. Inc. (KKR)<\/strong> \u2014 Oppenheimer maintains its Outperform rating and lowers its price target to $156.00 from $163.00.<\/p>\n

KKR & Co. Inc. (KKR)<\/strong> \u2014 Royal Bank Of Canada reiterates its Outperform rating with a price target of $134.00.<\/p>\n

KKR & Co. Inc. (KKR)<\/strong> \u2014 Wells Fargo & Company maintains its Equal Weight rating and raises its price target to $105.00 from $97.00.<\/p>\n

Kodiak Gas Services (KGS)<\/strong> \u2014 Jefferies Financial Group maintains its Buy rating and lowers its price target to $52.00 from $53.00.<\/p>\n

Kodiak Gas Services (KGS)<\/strong> \u2014 Mizuho maintains its Outperform rating and lowers its price target to $68.00 from $72.00.<\/p>\n

Kodiak Gas Services (KGS)<\/strong> \u2014 Raymond James Financial reiterates its Outperform rating with a price target of $70.00.<\/p>\n

Kodiak Gas Services (KGS)<\/strong> \u2014 Royal Bank Of Canada maintains its Outperform rating and lowers its price target to $78.00 from $82.00.<\/p>\n

Kodiak Gas Services (KGS)<\/strong> \u2014 Stifel Nicolaus maintains its Buy rating and lowers its price target to $90.00 from $92.00.<\/p>\n

Kratos Defense & Security Solutions (KTOS)<\/strong> \u2014 Barclays maintains its Overweight rating and lowers its price target to $80.00 from $90.00.<\/p>\n

Larimar Therapeutics (LRMR)<\/strong> \u2014 Wedbush reiterates its Outperform rating.<\/p>\n

LegalZoom.com (LZ)<\/strong> \u2014 Citigroup maintains its Neutral rating and lowers its price target to $5.50 from $6.00.<\/p>\n

Leidos (LDOS)<\/strong> \u2014 Citigroup maintains its Buy rating and raises its price target to $163.00 from $141.00.<\/p>\n

LENSAR (LNSR)<\/strong> \u2014 BTIG Research maintains its Buy rating and lowers its price target to $9.00 from $10.00.<\/p>\n

Liberty Media Corporation – Liberty Formula One Series A (FWONA)<\/strong> \u2014 TD Cowen maintains its Buy rating and raises its price target to $113.00 from $107.00.<\/p>\n

Liberty Media Corporation – Liberty Formula One Series C (FWONK)<\/strong> \u2014 TD Cowen maintains its Buy rating and raises its price target to $125.00 from $118.00.<\/p>\n

Lincoln Educational Services (LINC)<\/strong> \u2014 B. Riley Financial maintains its Buy rating and lowers its price target to $50.00 from $52.00.<\/p>\n

Lincoln Educational Services (LINC)<\/strong> \u2014 Rosenblatt Securities maintains its Buy rating and lowers its price target to $40.00 from $50.00.<\/p>\n

Liquidia (LQDA)<\/strong> \u2014 BTIG Research maintains its Buy rating and raises its price target to $87.00 from $70.00.<\/p>\n

Liquidia (LQDA)<\/strong> \u2014 Jefferies Financial Group maintains its Buy rating and raises its price target to $62.00 from $55.00.<\/p>\n

Live Nation Entertainment (LYV)<\/strong> \u2014 Oppenheimer maintains its Outperform rating and raises its price target to $215.00 from $210.00.<\/p>\n

loanDepot (LDI)<\/strong> \u2014 Bank of America reiterates its Underperform rating.<\/p>\n

Lowe’s Companies (LOW)<\/strong> \u2014 Sanford C. Bernstein maintains its Outperform rating and raises its price target to $270.00 from $254.00.<\/p>\n

LPL Financial (LPLA)<\/strong> \u2014 Morgan Stanley maintains its Overweight rating and raises its price target to $399.00 from $393.00.<\/p>\n

LTC Properties (LTC)<\/strong> \u2014 Royal Bank Of Canada maintains its Outperform rating and raises its price target to $53.00 from $52.00.<\/p>\n

Lucid Group (LCID)<\/strong> \u2014 Cantor Fitzgerald maintains its Neutral rating and lowers its price target to $6.00 from $8.00.<\/p>\n

Lucid Group (LCID)<\/strong> \u2014 Needham & Company LLC reiterates its Hold rating.<\/p>\n

Lucid Group (LCID)<\/strong> \u2014 Robert W. Baird maintains its Neutral rating and lowers its price target to $5.00 from $6.00.<\/p>\n

Lucid Group (LCID)<\/strong> \u2014 TD Cowen maintains its Hold rating and lowers its price target to $4.00 from $7.00.<\/p>\n

lululemon athletica (LULU)<\/strong> \u2014 Cantor Fitzgerald initiates coverage with a Neutral rating with a price target of $121.00.<\/p>\n

Lumentum (LITE)<\/strong> \u2014 Sanford C. Bernstein maintains its Outperform rating and raises its price target to $700.00 from $635.00.<\/p>\n

Lumentum (LITE)<\/strong> \u2014 UBS Group maintains its Neutral rating and lowers its price target to $686.00 from $960.00.<\/p>\n

Magnolia Oil & Gas (MGY)<\/strong> \u2014 Citigroup maintains its Neutral rating and lowers its price target to $26.00 from $27.00.<\/p>\n

Magnolia Oil & Gas (MGY)<\/strong> \u2014 Gerdes Energy Research upgrades the stock to Neutral ? Buy with a price target of $29.00.<\/p>\n

Main Street Capital (MAIN)<\/strong> \u2014 Wells Fargo & Company maintains its Overweight rating and lowers its price target to $59.00 from $60.00.<\/p>\n

MARA (MARA)<\/strong> \u2014 Compass Point reiterates its Buy rating with a price target of $20.00.<\/p>\n

MARA (MARA)<\/strong> \u2014 Guggenheim reiterates its Neutral rating.<\/p>\n

MARA (MARA)<\/strong> \u2014 Rosenblatt Securities maintains its Buy rating and lowers its price target to $11.00 from $15.00.<\/p>\n

Martin Marietta Materials (MLM)<\/strong> \u2014 B. Riley Financial maintains its Buy rating and lowers its price target to $615.00 from $700.00.<\/p>\n

Mastercard (MA)<\/strong> \u2014 Citigroup maintains its Buy rating and raises its price target to $800.00 from $675.00.<\/p>\n

Maze Therapeutics (MAZE)<\/strong> \u2014 Wedbush maintains its Outperform rating and raises its price target to $49.00 from $48.00.<\/p>\n

McEwen (MUX)<\/strong> \u2014 HC Wainwright maintains its Buy rating and lowers its price target to $27.00 from $28.00.<\/p>\n

McKesson (MCK)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Overweight rating and raises its price target to $1,255.00 from $1,042.00.<\/p>\n

MDA Space (MDA)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Overweight rating and lowers its price target to $44.00 from $50.00.<\/p>\n

Mereo BioPharma Group (MREO)<\/strong> \u2014 BTIG Research reiterates its Buy rating with a price target of $1.00.<\/p>\n

Mesa Laboratories (MLAB)<\/strong> \u2014 Jefferies Financial Group maintains its Buy rating and raises its price target to $150.00 from $125.00.<\/p>\n

Microsoft (MSFT)<\/strong> \u2014 Royal Bank Of Canada reiterates its Outperform rating.<\/p>\n

Microvast (MVST)<\/strong> \u2014 Cantor Fitzgerald maintains its Overweight rating and lowers its price target to $2.00.<\/p>\n

Mid-America Apartment Communities (MAA)<\/strong> \u2014 UBS Group maintains its Neutral rating and raises its price target to $128.00 from $123.00.<\/p>\n

MidCap Financial Investment (MFIC)<\/strong> \u2014 Royal Bank Of Canada maintains its Sector Perform rating and raises its price target to $11.00 from $10.00.<\/p>\n

monday.com (MNDY)<\/strong> \u2014 Bank of America reiterates its Neutral rating.<\/p>\n

monday.com (MNDY)<\/strong> \u2014 Barclays maintains its Equal Weight rating and lowers its price target to $91.00 from $100.00.<\/p>\n

monday.com (MNDY)<\/strong> \u2014 BTIG Research maintains its Buy rating and lowers its price target to $100.00 from $105.00.<\/p>\n

monday.com (MNDY)<\/strong> \u2014 Citigroup maintains its Buy rating and lowers its price target to $127.00 from $132.00.<\/p>\n

monday.com (MNDY)<\/strong> \u2014 Jefferies Financial Group maintains its Hold rating and lowers its price target to $90.00 from $95.00.<\/p>\n

monday.com (MNDY)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Neutral rating and lowers its price target to $84.00 from $87.00.<\/p>\n

monday.com (MNDY)<\/strong> \u2014 Morgan Stanley maintains its Overweight rating and lowers its price target to $109.00 from $115.00.<\/p>\n

monday.com (MNDY)<\/strong> \u2014 TD Cowen maintains its Hold rating and lowers its price target to $95.00 from $105.00.<\/p>\n

monday.com (MNDY)<\/strong> \u2014 UBS Group maintains its Neutral rating and lowers its price target to $90.00 from $95.00.<\/p>\n

monday.com (MNDY)<\/strong> \u2014 Wells Fargo & Company maintains its Overweight rating and lowers its price target to $100.00 from $120.00.<\/p>\n

MongoDB (MDB)<\/strong> \u2014 BTIG Research initiates coverage with a Buy rating with a price target of $417.00.<\/p>\n

Morgan Stanley Direct Lending (MSDL)<\/strong> \u2014 UBS upgrades the stock from Neutral to Buy and lowers its price target to $14.50 from $15.50.<\/p>\n

Motorcar Parts of America (MPAA)<\/strong> \u2014 Cantor Fitzgerald maintains its Overweight rating and lowers its price target to $18.00 from $20.00.<\/p>\n

MP Materials (MP)<\/strong> \u2014 Freedom Broker upgrades the stock from Hold to Buy with a price target of $51.00.<\/p>\n

Mplx (MPLX)<\/strong> \u2014 Morgan Stanley maintains its Equal Weight rating and lowers its price target to $60.00 from $64.00.<\/p>\n

National Energy Services Reunited (NESR)<\/strong> \u2014 Barclays maintains its Overweight rating and lowers its price target to $37.00 from $41.00.<\/p>\n

National Energy Services Reunited (NESR)<\/strong> \u2014 UBS Group maintains its Buy rating and lowers its price target to $40.00 from $46.00.<\/p>\n

NerdWallet (NRDS)<\/strong> \u2014 Citigroup maintains its Neutral rating and lowers its price target to $8.50 from $11.00.<\/p>\n

Nerdy (NRDY)<\/strong> \u2014 Needham & Company LLC maintains its Buy rating and raises its price target to $8.00 from $2.00.<\/p>\n

Neurogene (NGNE)<\/strong> \u2014 HC Wainwright maintains its Buy rating and lowers its price target to $60.00 from $65.00.<\/p>\n

NexPoint Real Estate Finance (NREF)<\/strong> \u2014 Keefe, Bruyette & Woods maintains its Market Perform rating and lowers its price target to $14.00 from $15.00.<\/p>\n

Nextpower (NXT)<\/strong> \u2014 Citigroup maintains its Buy rating and raises its price target to $126.00 from $119.00.<\/p>\n

NIKE (NKE)<\/strong> \u2014 Cantor Fitzgerald initiates coverage with a Neutral rating with a price target of $38.00.<\/p>\n

NMI (NMIH)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Overweight rating and raises its price target to $46.00 from $45.00.<\/p>\n

NNN REIT (NNN)<\/strong> \u2014 Truist Financial maintains its Hold rating and raises its price target to $46.00 from $45.00.<\/p>\n

NovoCure (NVCR)<\/strong> \u2014 LADENBURG THALM\/SH SH maintains its Buy rating and raises its price target to $31.00 from $27.00.<\/p>\n

NovoCure (NVCR)<\/strong> \u2014 Wedbush maintains its Neutral rating and lowers its price target to $19.00 from $20.00.<\/p>\n

NRG Energy (NRG)<\/strong> \u2014 Raymond James Financial maintains its Strong-Buy rating and sets a price target of $150.00.<\/p>\n

NVIDIA (NVDA)<\/strong> \u2014 Citigroup maintains its Buy rating and lowers its price target to $285.00 from $315.00.<\/p>\n

NVIDIA (NVDA)<\/strong> \u2014 Wells Fargo & Company maintains its Overweight rating and lowers its price target to $300.00 from $315.00.<\/p>\n

Ocular Therapeutix (OCUL)<\/strong> \u2014 HC Wainwright maintains its Buy rating and raises its price target to $28.00 from $25.00.<\/p>\n

On (ONON)<\/strong> \u2014 Cantor Fitzgerald initiates coverage with an Overweight rating with a price target of $46.00.<\/p>\n

ONEOK (OKE)<\/strong> \u2014 Barclays resumes coverage with an Equal Weight rating with a price target of $94.00.<\/p>\n

Onto Innovation (ONTO)<\/strong> \u2014 Jefferies Financial Group maintains its Buy rating and lowers its price target to $350.00 from $400.00.<\/p>\n

Onto Innovation (ONTO)<\/strong> \u2014 Morgan Stanley maintains its Overweight rating and lowers its price target to $325.00 from $360.00.<\/p>\n

Onto Innovation (ONTO)<\/strong> \u2014 Needham & Company LLC maintains its Buy rating and lowers its price target to $285.00 from $360.00.<\/p>\n

Onto Innovation (ONTO)<\/strong> \u2014 Royal Bank Of Canada maintains its Outperform rating and lowers its price target to $350.00 from $400.00.<\/p>\n

Onto Innovation (ONTO)<\/strong> \u2014 Stifel Nicolaus maintains its Buy rating and lowers its price target to $305.00 from $350.00.<\/p>\n

Oracle (ORCL)<\/strong> \u2014 KeyCorp reiterates its Overweight rating.<\/p>\n

Orion (OEC)<\/strong> \u2014 JPMorgan Chase & Co. upgrades the stock to Underweight ? Neutral.<\/p>\n

Orion Engineered Carbons (OEC)<\/strong> \u2014 JP Morgan upgrades the stock from Underweight to Neutral.<\/p>\n

Orthofix Medical (OFIX)<\/strong> \u2014 TD Cowen reiterates its Hold rating.<\/p>\n

Oruka Therapeutics (ORKA)<\/strong> \u2014 BTIG Research reiterates its Buy rating with a price target of $151.00.<\/p>\n

Palomar (PLMR)<\/strong> \u2014 Keefe, Bruyette & Woods maintains its Outperform rating and raises its price target to $172.00 from $161.00.<\/p>\n

Park Hotels & Resorts (PK)<\/strong> \u2014 Cantor Fitzgerald maintains its Neutral rating and raises its price target to $17.00 from $15.00.<\/p>\n

Parsons (PSN)<\/strong> \u2014 Citigroup maintains its Buy rating and raises its price target to $63.00 from $53.00.<\/p>\n

Patterson-UTI Energy (PTEN)<\/strong> \u2014 Citigroup maintains its Neutral rating and lowers its price target to $11.00 from $12.50.<\/p>\n

Peabody Energy (BTU)<\/strong> \u2014 Jefferies downgrades the stock from Buy to Hold and lowers its price target to $18.00 from $30.00.<\/p>\n

Pebblebrook Hotel Trust (PEB)<\/strong> \u2014 Cantor Fitzgerald maintains its Neutral rating and raises its price target to $23.00 from $19.00.<\/p>\n

PepGen (PEPG)<\/strong> \u2014 BofA Securities upgrades the stock from Underperform to Neutral with a price target of $6.00.<\/p>\n

Philip Morris International (PM)<\/strong> \u2014 JP Morgan resumes coverage with a Neutral rating with a price target of $200.00.<\/p>\n

Philip Morris International (PM)<\/strong> \u2014 JPMorgan Chase & Co. initiates coverage with a Neutral rating with a price target of $200.00.<\/p>\n

Planet Fitness (PLNT)<\/strong> \u2014 Jefferies Financial Group reiterates its Buy rating.<\/p>\n

Plug Power (PLUG)<\/strong> \u2014 Craig Hallum reiterates its Buy rating.<\/p>\n

Plug Power (PLUG)<\/strong> \u2014 HC Wainwright reiterates its Buy rating with a price target of $7.00.<\/p>\n

Plug Power (PLUG)<\/strong> \u2014 KeyCorp sets a price target of $3.00.<\/p>\n

Plug Power (PLUG)<\/strong> \u2014 Oppenheimer reiterates its Market Perform rating.<\/p>\n

Plug Power (PLUG)<\/strong> \u2014 Royal Bank Of Canada reiterates its Sector Perform rating with a price target of $2.00.<\/p>\n

Praxis Precision Medicines (PRAX)<\/strong> \u2014 Royal Bank Of Canada maintains its Outperform rating and raises its price target to $478.00 from $462.00.<\/p>\n

Praxis Precision Medicines (PRAX)<\/strong> \u2014 Wedbush maintains its Underperform rating and raises its price target to $189.00 from $188.00.<\/p>\n

Praxis Precision Medicines (PRAX)<\/strong> \u2014 Wells Fargo & Company maintains its Equal Weight rating and lowers its price target to $343.00 from $362.00.<\/p>\n

Primo Brands (PRMB)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Overweight rating and raises its price target to $27.00 from $26.00.<\/p>\n

PubMatic (PUBM)<\/strong> \u2014 B. Riley Financial maintains its Buy rating and raises its price target to $24.00 from $21.00.<\/p>\n

PubMatic (PUBM)<\/strong> \u2014 Rosenblatt Securities maintains its Buy rating and raises its price target to $25.00 from $23.00.<\/p>\n

PubMatic (PUBM)<\/strong> \u2014 Royal Bank Of Canada maintains its Outperform rating and raises its price target to $22.00 from $20.00.<\/p>\n

PubMatic (PUBM)<\/strong> \u2014 UBS Group reiterates its Buy rating.<\/p>\n

Qualys (QLYS)<\/strong> \u2014 Jefferies Financial Group maintains its Hold rating and lowers its price target to $215.00 from $235.00.<\/p>\n

Qualys (QLYS)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Neutral rating and lowers its price target to $215.00 from $241.00.<\/p>\n

Qualys (QLYS)<\/strong> \u2014 Morgan Stanley maintains its Underweight rating and raises its price target to $140.00 from $130.00.<\/p>\n

Qualys (QLYS)<\/strong> \u2014 Piper Sandler maintains its Neutral rating and raises its price target to $185.00 from $175.00.<\/p>\n

Qualys (QLYS)<\/strong> \u2014 Robert W. Baird maintains its Neutral rating and raises its price target to $210.00 from $160.00.<\/p>\n

Qualys (QLYS)<\/strong> \u2014 Royal Bank Of Canada maintains its Sector Perform rating and raises its price target to $197.00 from $180.00.<\/p>\n

Qualys (QLYS)<\/strong> \u2014 UBS Group maintains its Neutral rating and raises its price target to $210.00 from $170.00.<\/p>\n

Qualys (QLYS)<\/strong> \u2014 Wedbush maintains its Neutral rating and raises its price target to $185.00 from $175.00.<\/p>\n

Quanterix (QTRX)<\/strong> \u2014 TD Cowen maintains its Hold rating and raises its price target to $4.00 from $3.50.<\/p>\n

Quantum (QMCO)<\/strong> \u2014 Cantor Fitzgerald maintains its Overweight rating and raises its price target to $32.00 from $29.00.<\/p>\n

Quantum Computing (QUBT)<\/strong> \u2014 Wedbush reiterates its Neutral rating.<\/p>\n

Radian Group (RDN)<\/strong> \u2014 Keefe, Bruyette & Woods maintains its Outperform rating and lowers its price target to $43.00 from $44.00.<\/p>\n

Radian Group (RDN)<\/strong> \u2014 Royal Bank Of Canada sets a price target of $43.00.<\/p>\n

RadNet (RDNT)<\/strong> \u2014 KeyCorp maintains its Overweight rating and raises its price target to $95.00 from $92.00.<\/p>\n

Ralph Lauren (RL)<\/strong> \u2014 Cantor Fitzgerald initiates coverage with an Overweight rating with a price target of $426.00.<\/p>\n

RB Global (RBA)<\/strong> \u2014 Royal Bank Of Canada maintains its Outperform rating and lowers its price target to $134.00 from $152.00.<\/p>\n

Realty Income (O)<\/strong> \u2014 Truist Financial maintains its Hold rating and raises its price target to $63.00 from $60.00.<\/p>\n

Reddit (RDDT)<\/strong> \u2014 Guggenheim maintains its Buy rating and lowers its price target to $140.00 from $170.00.<\/p>\n

Remitly Global (RELY)<\/strong> \u2014 KeyCorp reiterates its Overweight rating.<\/p>\n

Repay (RPAY)<\/strong> \u2014 Canaccord Genuity Group maintains its Buy rating and lowers its price target to $7.00 from $8.00.<\/p>\n

Repay (RPAY)<\/strong> \u2014 UBS Group maintains its Neutral rating and raises its price target to $4.75 from $4.25.<\/p>\n

Riot Platforms (RIOT)<\/strong> \u2014 Jefferies upgrades the stock from Hold to Buy with a price target of $28.00.<\/p>\n

RLJ Lodging Trust (RLJ)<\/strong> \u2014 Oppenheimer maintains its Outperform rating and raises its price target to $15.00 from $13.00.<\/p>\n

Rocket Lab (RKLB)<\/strong> \u2014 Barclays maintains its Overweight rating and lowers its price target to $82.00 from $85.00.<\/p>\n

Rocket Lab (RKLB)<\/strong> \u2014 BTIG Research reiterates its Neutral rating.<\/p>\n

Rocket Lab (RKLB)<\/strong> \u2014 Cantor Fitzgerald maintains its Overweight rating and lowers its price target to $111.00 from $122.00.<\/p>\n

Rocket Lab (RKLB)<\/strong> \u2014 KeyCorp reiterates its Overweight rating with a price target of $100.00.<\/p>\n

Rocket Lab (RKLB)<\/strong> \u2014 Piper Sandler maintains its Neutral rating and lowers its price target to $58.00 from $83.00.<\/p>\n

Roivant Sciences (ROIV)<\/strong> \u2014 HC Wainwright maintains its Buy rating and raises its price target to $48.00 from $47.00.<\/p>\n

Roku (ROKU)<\/strong> \u2014 Wedbush maintains its Neutral rating.<\/p>\n

Ross Stores (ROST)<\/strong> \u2014 Cantor Fitzgerald initiates coverage with an Overweight rating with a price target of $276.00.<\/p>\n

RPM International (RPM)<\/strong> \u2014 Royal Bank Of Canada maintains its Outperform rating and raises its price target to $125.00 from $120.00.<\/p>\n

Ryman Hospitality Properties (RHP)<\/strong> \u2014 Cantor Fitzgerald maintains its Overweight rating and raises its price target to $152.00 from $135.00.<\/p>\n

Sally Beauty (SBH)<\/strong> \u2014 Raymond James Financial maintains its Outperform rating and sets a price target of $18.00.<\/p>\n

SandRidge Energy (SD)<\/strong> \u2014 Freedom Broker upgrades the stock from Hold to Buy with a price target of $14.00.<\/p>\n

Sanmina (SANM)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Neutral rating and lowers its price target to $230.00 from $270.00.<\/p>\n

Sarepta Therapeutics (SRPT)<\/strong> \u2014 Deutsche Bank upgrades the stock from Sell to Hold with a price target of $18.00.<\/p>\n

Sarepta Therapeutics (SRPT)<\/strong> \u2014 Deutsche Bank Aktiengesellschaft upgrades the stock to Sell ? Hold and raises its price target to $18.00 from $14.00.<\/p>\n

Scholar Rock (SRRK)<\/strong> \u2014 Raymond James Financial reiterates its Strong-Buy rating.<\/p>\n

SEA (SE)<\/strong> \u2014 Jefferies Financial Group maintains its Buy rating and lowers its price target to $142.00 from $164.00.<\/p>\n

Securitize (SECZ)<\/strong> \u2014 Needham & Company LLC maintains its Buy rating and raises its price target to $13.00 from $11.00.<\/p>\n

Securitize (SECZ)<\/strong> \u2014 Rosenblatt Securities maintains its Buy rating and lowers its price target to $12.00 from $13.00.<\/p>\n

Securitize, Inc. (SECZ)<\/strong> \u2014 Citigroup upgrades the stock from Neutral to Buy with a price target of $14.00.<\/p>\n

Sensei Biotherapeutics (FTH)<\/strong> \u2014 Citigroup maintains its Buy rating and raises its price target to $60.00 from $55.00.<\/p>\n

Senseonics (SENS)<\/strong> \u2014 Raymond James upgrades the stock from Underperform to Market Perform.<\/p>\n

Senseonics Holdings, Inc. Common Stock (SENS)<\/strong> \u2014 Barclays maintains its Equal Weight rating and raises its price target to $11.00 from $10.00.<\/p>\n

Senseonics Holdings, Inc. Common Stock (SENS)<\/strong> \u2014 HC Wainwright reiterates its Buy rating with a price target of $14.00.<\/p>\n

Senseonics Holdings, Inc. Common Stock (SENS)<\/strong> \u2014 Mizuho maintains its Outperform rating and raises its price target to $20.00 from $18.00.<\/p>\n

Senseonics Holdings, Inc. Common Stock (SENS)<\/strong> \u2014 Stifel Nicolaus maintains its Hold rating and raises its price target to $10.00 from $9.00.<\/p>\n

Senseonics Holdings, Inc. Common Stock (SENS)<\/strong> \u2014 TD Cowen maintains its Buy rating and raises its price target to $17.00 from $15.00.<\/p>\n

Septerna (SEPN)<\/strong> \u2014 Stifel Nicolaus maintains its Buy rating and raises its price target to $60.00 from $49.00.<\/p>\n

Shake Shack (SHAK)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Neutral rating and raises its price target to $77.00 from $75.00.<\/p>\n

Sharplink Gaming (SBET)<\/strong> \u2014 B. Riley Financial maintains its Buy rating and lowers its price target to $11.00 from $14.00.<\/p>\n

Shift4 Payments (FOUR)<\/strong> \u2014 Mizuho maintains its Outperform rating and raises its price target to $56.00 from $46.00.<\/p>\n

Sirius XM (SIRI)<\/strong> \u2014 UBS Group sets a price target of $27.00.<\/p>\n

Skydance (SKYD)<\/strong> \u2014 Citizens Jmp maintains its Market Outperform rating and lowers its price target to $13.00 from $14.00.<\/p>\n

Skydance (SKYD)<\/strong> \u2014 Wells Fargo & Company maintains its Underweight rating and raises its price target to $8.00 from $7.00.<\/p>\n

Skyworks Solutions (SWKS)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Neutral rating and raises its price target to $77.00 from $65.00.<\/p>\n

Somnigroup International (SGI)<\/strong> \u2014 KeyCorp maintains its Overweight rating and lowers its price target to $100.00 from $105.00.<\/p>\n

Somnigroup International (SGI)<\/strong> \u2014 Morgan Stanley maintains its Overweight rating and lowers its price target to $90.00 from $95.00.<\/p>\n

Somnigroup International (SGI)<\/strong> \u2014 UBS Group maintains its Buy rating and lowers its price target to $87.00 from $102.00.<\/p>\n

Southern Copper (SCCO)<\/strong> \u2014 UBS upgrades the stock from Sell to Neutral with a price target of $180.00.<\/p>\n

Sterling Infrastructure (STRL)<\/strong> \u2014 JP Morgan initiates coverage with an Overweight rating with a price target of $585.00.<\/p>\n

Sterling Infrastructure (STRL)<\/strong> \u2014 JPMorgan Chase & Co. initiates coverage with an Overweight rating with a price target of $585.00.<\/p>\n

Sun Communities (SUI)<\/strong> \u2014 Robert W. Baird maintains its Neutral rating and lowers its price target to $131.00 from $138.00.<\/p>\n

Super Micro Computer (SMCI)<\/strong> \u2014 Susquehanna maintains its Negative rating and raises its price target to $18.00 from $15.00.<\/p>\n

Surgery Partners (SGRY)<\/strong> \u2014 Royal Bank Of Canada maintains its Sector Perform rating and raises its price target to $25.00 from $23.50.<\/p>\n

Surrozen (SRZN)<\/strong> \u2014 Cantor Fitzgerald maintains its Overweight rating and raises its price target to $62.00 from $40.00.<\/p>\n

Take-Two Interactive Software (TTWO)<\/strong> \u2014 BMO Capital Markets reiterates its Outperform rating.<\/p>\n

Take-Two Interactive Software (TTWO)<\/strong> \u2014 BTIG Research reiterates its Buy rating with a price target of $262.00.<\/p>\n

Take-Two Interactive Software (TTWO)<\/strong> \u2014 Jefferies Financial Group reiterates its Buy rating.<\/p>\n

Take-Two Interactive Software (TTWO)<\/strong> \u2014 Oppenheimer reiterates its Outperform rating.<\/p>\n

Take-Two Interactive Software (TTWO)<\/strong> \u2014 TD Cowen reiterates its Buy rating.<\/p>\n

Take-Two Interactive Software (TTWO)<\/strong> \u2014 UBS Group maintains its Buy rating and lowers its price target to $295.00 from $300.00.<\/p>\n

Tango Therapeutics (TNGX)<\/strong> \u2014 HC Wainwright maintains its Buy rating and lowers its price target to $67.00 from $68.00.<\/p>\n

Tango Therapeutics (TNGX)<\/strong> \u2014 Jefferies Financial Group reiterates its Buy rating with a price target of $65.00.<\/p>\n

Tango Therapeutics (TNGX)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Overweight rating and raises its price target to $47.00 from $46.00.<\/p>\n

Tango Therapeutics (TNGX)<\/strong> \u2014 Wedbush maintains its Outperform rating and lowers its price target to $40.00 from $45.00.<\/p>\n

Tapestry (TPR)<\/strong> \u2014 Cantor Fitzgerald initiates coverage with an Overweight rating with a price target of $159.00.<\/p>\n

Targa Resources (TRGP)<\/strong> \u2014 Morgan Stanley maintains its Overweight rating and raises its price target to $362.00 from $359.00.<\/p>\n

Targa Resources (TRGP)<\/strong> \u2014 Scotiabank maintains its Sector Outperform rating and raises its price target to $325.00 from $319.00.<\/p>\n

Telos (TLS)<\/strong> \u2014 B. Riley Financial maintains its Buy rating and raises its price target to $11.00 from $9.00.<\/p>\n

Telos (TLS)<\/strong> \u2014 Needham & Company LLC maintains its Buy rating and raises its price target to $9.00 from $6.00.<\/p>\n

Telos (TLS)<\/strong> \u2014 Wedbush maintains its Neutral rating and raises its price target to $7.00 from $5.00.<\/p>\n

TeraWulf (WULF)<\/strong> \u2014 Citigroup maintains its Buy rating and lowers its price target to $24.00 from $31.00.<\/p>\n

TeraWulf (WULF)<\/strong> \u2014 Jefferies Financial Group maintains its Buy rating and lowers its price target to $14.00 from $15.00.<\/p>\n

TeraWulf (WULF)<\/strong> \u2014 Morgan Stanley maintains its Overweight rating and lowers its price target to $47.00 from $65.00.<\/p>\n

TeraWulf (WULF)<\/strong> \u2014 Wells Fargo & Company maintains its Overweight rating and lowers its price target to $22.00 from $30.00.<\/p>\n

Terreno Realty (TRNO)<\/strong> \u2014 BTIG Research reiterates its Buy rating with a price target of $80.00.<\/p>\n

TJX (TJX)<\/strong> \u2014 Cantor Fitzgerald initiates coverage with a Neutral rating with a price target of $139.00.<\/p>\n

TJX Companies (TJX)<\/strong> \u2014 UBS Group maintains its Buy rating and lowers its price target to $184.00 from $198.00.<\/p>\n

Toast (TOST)<\/strong> \u2014 Truist Financial maintains its Buy rating and raises its price target to $40.00 from $38.00.<\/p>\n

Trade Desk (TTD)<\/strong> \u2014 Citigroup maintains its Sell rating and raises its price target to $12.00 from $11.00.<\/p>\n

Trade Desk (TTD)<\/strong> \u2014 Guggenheim maintains its Neutral rating and raises its price target to $16.00 from $13.00.<\/p>\n

Trade Desk (TTD)<\/strong> \u2014 KeyCorp reiterates its Sector Weight rating.<\/p>\n

Trade Desk (TTD)<\/strong> \u2014 Morgan Stanley maintains its Equal Weight rating and raises its price target to $14.00 from $13.00.<\/p>\n

Trade Desk (TTD)<\/strong> \u2014 Needham & Company LLC reiterates its Buy rating with a price target of $19.00.<\/p>\n

Trade Desk (TTD)<\/strong> \u2014 Rosenblatt Securities maintains its Neutral rating and raises its price target to $15.00 from $12.00.<\/p>\n

Trade Desk (TTD)<\/strong> \u2014 Royal Bank Of Canada maintains its Sector Perform rating and raises its price target to $18.00 from $15.00.<\/p>\n

Trade Desk (TTD)<\/strong> \u2014 Scotiabank maintains its Sector Perform rating and raises its price target to $15.00 from $12.00.<\/p>\n

Trade Desk (TTD)<\/strong> \u2014 Susquehanna maintains its Neutral rating and raises its price target to $17.00 from $14.00.<\/p>\n

Trade Desk (TTD)<\/strong> \u2014 Truist Financial maintains its Hold rating and sets a price target of $17.00 from $16.00.<\/p>\n

Trade Desk (TTD)<\/strong> \u2014 UBS Group maintains its Buy rating and raises its price target to $19.00 from $15.00.<\/p>\n

Trade Desk (TTD)<\/strong> \u2014 Wedbush reiterates its Neutral rating with a price target of $15.00.<\/p>\n

Trex (TREX)<\/strong> \u2014 DA Davidson downgrades the stock from Buy to Neutral with a price target of $55.00.<\/p>\n

Turning Point Brands (TPB)<\/strong> \u2014 Needham & Company LLC maintains its Buy rating and lowers its price target to $95.00 from $125.00.<\/p>\n

TWFG (TWFG)<\/strong> \u2014 Morgan Stanley maintains its Overweight rating and raises its price target to $31.00 from $30.00.<\/p>\n

TWFG (TWFG)<\/strong> \u2014 UBS Group maintains its Buy rating and raises its price target to $36.00 from $34.00.<\/p>\n

United Dominion Realty Trust (UDR)<\/strong> \u2014 UBS Group maintains its Buy rating and raises its price target to $43.00 from $39.00.<\/p>\n

United Parks & Resorts (PRKS)<\/strong> \u2014 Guggenheim maintains its Buy rating and raises its price target to $56.00 from $54.00.<\/p>\n

Uniti Group (UNIT)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Neutral rating and lowers its price target to $9.00 from $11.00.<\/p>\n

Uniti Group (UNIT)<\/strong> \u2014 Raymond James Financial reiterates its Strong-Buy rating with a price target of $12.00.<\/p>\n

Uniti Group (UNIT)<\/strong> \u2014 Wells Fargo & Company maintains its Equal Weight rating and lowers its price target to $4.00 from $9.00.<\/p>\n

Unum Group (UNM)<\/strong> \u2014 Morgan Stanley maintains its Equal Weight rating and lowers its price target to $85.00 from $92.00.<\/p>\n

USA Rare Earth (USAR)<\/strong> \u2014 Cantor Fitzgerald maintains its Overweight rating and lowers its price target to $30.00 from $40.00.<\/p>\n

V2X (VVX)<\/strong> \u2014 Citigroup maintains its Neutral rating and raises its price target to $83.00 from $75.00.<\/p>\n

Venture Global (VG)<\/strong> \u2014 Sanford C. Bernstein reiterates its Market Perform rating with a price target of $14.00.<\/p>\n

Veracyte (VCYT)<\/strong> \u2014 Piper Sandler maintains its Overweight rating and lowers its price target to $30.00 from $54.00.<\/p>\n

Veradermics (MANE)<\/strong> \u2014 Citigroup maintains its Buy rating and raises its price target to $175.00 from $160.00.<\/p>\n

Vericel (VCEL)<\/strong> \u2014 Stephens maintains its Overweight rating and raises its price target to $68.00 from $55.00.<\/p>\n

Verisk Analytics (VRSK)<\/strong> \u2014 Raymond James Financial reiterates its Strong-Buy rating with a price target of $245.00.<\/p>\n

Via Transportation (VIA)<\/strong> \u2014 Citigroup reiterates its Market Outperform rating.<\/p>\n

Via Transportation (VIA)<\/strong> \u2014 Citizens Jmp maintains its Market Outperform rating and raises its price target to $55.00 from $37.00.<\/p>\n

Via Transportation (VIA)<\/strong> \u2014 Guggenheim maintains its Buy rating and raises its price target to $58.00 from $50.00.<\/p>\n

Via Transportation (VIA)<\/strong> \u2014 Morgan Stanley maintains its Overweight rating and raises its price target to $48.00 from $33.00.<\/p>\n

Via Transportation (VIA)<\/strong> \u2014 Wells Fargo & Company maintains its Overweight rating and raises its price target to $50.00 from $32.00.<\/p>\n

Viant Technology (DSP)<\/strong> \u2014 DA Davidson initiates coverage with a Buy rating.<\/p>\n

Viant Technology (DSP)<\/strong> \u2014 UBS Group maintains its Buy rating and lowers its price target to $18.00 from $19.00.<\/p>\n

Vir Biotechnology (VIR)<\/strong> \u2014 Morgan Stanley maintains its Overweight rating and raises its price target to $28.00 from $25.00.<\/p>\n

Virtus Investment Partners (VRTS)<\/strong> \u2014 Piper Sandler maintains its Overweight rating and raises its price target to $162.00 from $146.00.<\/p>\n

Visa (V)<\/strong> \u2014 Citigroup maintains its Buy rating and raises its price target to $490.00 from $440.00.<\/p>\n

Vistance Networks (VISN)<\/strong> \u2014 Northland Capital downgrades the stock from Outperform to Market Perform with a price target of $4.00.<\/p>\n

Vistance Networks (VISN)<\/strong> \u2014 Northland Securities downgrades the stock to Outperform ? Market Perform with a price target of $4.00.<\/p>\n

Vital Farms (VITL)<\/strong> \u2014 UBS Group reiterates its Buy rating with a price target of $18.00.<\/p>\n

Vivid Seats (SEAT)<\/strong> \u2014 Royal Bank Of Canada maintains its Sector Perform rating and lowers its price target to $4.00 from $9.00.<\/p>\n

Voyager Technologies (VOYG)<\/strong> \u2014 Citigroup maintains its Buy rating and lowers its price target to $41.00 from $54.00.<\/p>\n

Walmart (WMT)<\/strong> \u2014 Mizuho maintains its Outperform rating and sets a price target of $135.00 from $125.00.<\/p>\n

Welltower (WELL)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Overweight rating and raises its price target to $273.00 from $260.00.<\/p>\n

Welltower (WELL)<\/strong> \u2014 Royal Bank Of Canada maintains its Outperform rating and raises its price target to $266.00 from $260.00.<\/p>\n

Western Midstream Partners (WES)<\/strong> \u2014 Stifel Nicolaus maintains its Buy rating and lowers its price target to $50.00 from $55.00.<\/p>\n

WhiteHorse Finance (WHF)<\/strong> \u2014 B. Riley Securities upgrades the stock from Neutral to Buy and raises its price target to $9.00 from $8.00.<\/p>\n

WhiteHorse Finance (WHF)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Underweight rating and raises its price target to $7.50 from $6.50.<\/p>\n

Wix.com (WIX)<\/strong> \u2014 BofA Securities downgrades the stock from Buy to Underperform and lowers its price target to $68.00 from $75.00.<\/p>\n

Wix.com (WIX)<\/strong> \u2014 Jefferies Financial Group reiterates its Buy rating with a price target of $85.00.<\/p>\n

Wix.com (WIX)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Underweight rating and lowers its price target to $59.00 from $62.00.<\/p>\n

Wix.com (WIX)<\/strong> \u2014 Wedbush reiterates its Neutral rating.<\/p>\n

XPLR Infrastructure (XIFR)<\/strong> \u2014 Jefferies Financial Group maintains its Buy rating and lowers its price target to $11.00 from $14.00.<\/p>\n

York Space Systems (YSS)<\/strong> \u2014 Citigroup maintains its Buy rating and lowers its price target to $10.00 from $13.00.<\/p>\n

Zentalis Pharma (ZNTL)<\/strong> \u2014 Wedbush upgrades the stock from Neutral to Outperform and raises its price target to $6.00 from $5.00.<\/p>\n

Zeta Global (ZETA)<\/strong> \u2014 B. Riley Financial maintains its Buy rating and raises its price target to $39.00 from $38.00.<\/p>\n

Zeta Global (ZETA)<\/strong> \u2014 Citigroup maintains its Buy rating and raises its price target to $38.00 from $35.00.<\/p>\n

Zeta Global (ZETA)<\/strong> \u2014 KeyCorp reiterates its Overweight rating with a price target of $38.00.<\/p>\n

Zeta Global (ZETA)<\/strong> \u2014 Needham & Company LLC reiterates its Buy rating.<\/p>\n

Zeta Global (ZETA)<\/strong> \u2014 Royal Bank Of Canada maintains its Outperform rating and raises its price target to $41.00 from $40.00.<\/p>\n

Zeta Global (ZETA)<\/strong> \u2014 Truist Financial maintains its Buy rating and raises its price target to $40.00 from $38.00.<\/p>\n

ZipRecruiter (ZIP)<\/strong> \u2014 UBS Group maintains its Neutral rating and raises its price target to $5.00 from $4.50.<\/p>\n

Zura Bio (ZURA)<\/strong> \u2014 Oppenheimer maintains its Outperform rating and lowers its price target to $5.00.<\/p>\n

Zymeworks (ZYME)<\/strong> \u2014 HC Wainwright maintains its Buy rating and raises its price target to $56.00 from $55.00.<\/p>\n

Zymeworks (ZYME)<\/strong> \u2014 TD Cowen maintains its Buy rating and raises its price target to $39.00 from $34.00.<\/p>\n

Zymeworks (ZYME)<\/strong> \u2014 Truist Financial maintains its Buy rating and raises its price target to $36.00 from $35.00.<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Analyst Ratings (USA) American analyst sentiment on November 10th is mixed but cautiously optimistic, with positive recommendations concentrated in technology, artificial intelligence infrastructure, biotechnology,…<\/p>\n","protected":false},"author":3,"featured_media":76991,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-76988","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"\nAmerican Analyst Updates: Nov 10th, 2026 | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updated-nov-10th-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"American Analyst Updates: Nov 10th, 2026\" \/>\n<meta property=\"og:description\" content=\"Analyst Ratings (USA) American analyst sentiment on November 10th is mixed but cautiously optimistic, with positive recommendations concentrated in technology, artificial intelligence infrastructure, biotechnology,…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updated-nov-10th-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-11T04:09:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-11T04:10:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2026\/11\/U.S.-Market-Analyst-Updates.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1672\" \/>\n\t<meta property=\"og:image:height\" content=\"941\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"36 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updated-nov-10th-2026\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updated-nov-10th-2026\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"American Analyst Updates: Nov 10th, 2026\",\"datePublished\":\"2026-11-11T04:09:44+00:00\",\"dateModified\":\"2026-11-11T04:10:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updated-nov-10th-2026\/\"},\"wordCount\":7535,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News & Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updated-nov-10th-2026\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updated-nov-10th-2026\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updated-nov-10th-2026\/\",\"name\":\"American Analyst Updates: Nov 10th, 2026 | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2026-11-11T04:09:44+00:00\",\"dateModified\":\"2026-11-11T04:10:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updated-nov-10th-2026\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updated-nov-10th-2026\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updated-nov-10th-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"American Analyst Updates: Nov 10th, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"American Analyst Updates: Nov 10th, 2026 | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updated-nov-10th-2026\/","og_locale":"en_US","og_type":"article","og_title":"American Analyst Updates: Nov 10th, 2026","og_description":"Analyst Ratings (USA) American analyst sentiment on November 10th is mixed but cautiously optimistic, with positive recommendations concentrated in technology, artificial intelligence infrastructure, biotechnology,…","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updated-nov-10th-2026\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2026-11-11T04:09:44+00:00","article_modified_time":"2026-11-11T04:10:51+00:00","og_image":[{"width":1672,"height":941,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2026\/11\/U.S.-Market-Analyst-Updates.png","type":"image\/png"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"36 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updated-nov-10th-2026\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updated-nov-10th-2026\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"American Analyst Updates: Nov 10th, 2026","datePublished":"2026-11-11T04:09:44+00:00","dateModified":"2026-11-11T04:10:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updated-nov-10th-2026\/"},"wordCount":7535,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News & Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updated-nov-10th-2026\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updated-nov-10th-2026\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updated-nov-10th-2026\/","name":"American Analyst Updates: Nov 10th, 2026 | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2026-11-11T04:09:44+00:00","dateModified":"2026-11-11T04:10:51+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updated-nov-10th-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updated-nov-10th-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updated-nov-10th-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"American Analyst Updates: Nov 10th, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76988","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=76988"}],"version-history":[{"count":3,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76988\/revisions"}],"predecessor-version":[{"id":76994,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76988\/revisions\/76994"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/76991"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=76988"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=76988"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=76988"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}